| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 156,1 M € | +22.0% | 127,9 M € | +29.7% | 98,7 M € | +54.0% | 64,1 M € | +19.0% | 53,8 M € | +2.1% | 52,7 M € | +7.0% | 49,2 M € | -6.0% | 52,4 M € | -0.8% | 52,8 M € | -7.8% | 57,3 M € | +6.0% | 54,0 M € | -18.1% | 65,9 M € | +35.6% | 48,6 M € | -3.4% | 50,3 M € | +9.0% | 46,2 M € | -16.1% | 55,0 M € | +12.3% | 49,0 M € | +45.5% | 33,7 M € | +20.2% | 28,0 M € | |
| EBITDA | 24,7 M € | +150.5% | 9,9 M € | -32.3% | 14,5 M € | +2.4% | 14,2 M € | +39.5% | 10,2 M € | +5.5% | 9,6 M € | -5.0% | 10,2 M € | +10.4% | 9,2 M € | -52.8% | 19,5 M € | +115.5% | 9,0 M € | -29.4% | 12,8 M € | -3.4% | 13,3 M € | +12.2% | 11,8 M € | +12.5% | 10,5 M € | +788.6% | 1,2 M € | -77.6% | 5,3 M € | -7.6% | 5,7 M € | +152.9% | -10,8 M € | -60.9% | -6,7 M € | |
| Operating profit | 15,9 M € | +212.7% | 5,1 M € | -27.0% | 7,0 M € | +19.0% | 5,9 M € | +14.4% | 5,1 M € | -7.5% | 5,5 M € | +0.6% | 5,5 M € | +114.2% | 2,6 M € | -55.2% | 5,7 M € | +40.4% | 4,1 M € | -25.7% | 5,5 M € | -15.4% | 6,5 M € | +4.3% | 6,2 M € | +26.1% | 4,9 M € | +232.3% | -3,7 M € | -238.4% | 2,7 M € | +354.2% | -1,1 M € | +93.3% | -15,7 M € | -62.0% | -9,7 M € | |
| Profit/loss | 7,2 M € | +328.8% | -3,2 M € | -158.1% | 5,4 M € | +11.1% | 4,9 M € | +7.8% | 4,5 M € | -4.5% | 4,8 M € | -6.3% | 5,1 M € | +92.7% | 2,6 M € | -50.2% | 5,3 M € | -14.0% | 6,2 M € | -53.7% | 13,3 M € | +160.4% | 5,1 M € | +167.7% | 1,9 M € | +352.7% | 421,4 k € | +105.8% | -7,2 M € | -192.6% | -2,5 M € | +59.6% | -6,1 M € | +83.4% | -36,8 M € | -183.5% | -13,0 M € | |
| Equity | 103,8 M € | +7.4% | 96,6 M € | -1.6% | 98,1 M € | +5.8% | 92,7 M € | +5.5% | 87,9 M € | +5.4% | 83,4 M € | +6.0% | 78,7 M € | +6.8% | 73,7 M € | +4.0% | 70,8 M € | +8.1% | 65,5 M € | +11.1% | 59,0 M € | +29.1% | 45,7 M € | +12.6% | 40,6 M € | +261.3% | -25,2 M € | +1.6% | -25,6 M € | -39.5% | -18,3 M € | -15.6% | -15,9 M € | -62.8% | -9,7 M € | -238.5% | 7,0 M € | |
| Total assets | 331,7 M € | +22.4% | 271,1 M € | +29.3% | 209,6 M € | +43.8% | 145,8 M € | +32.2% | 110,3 M € | +1.3% | 108,9 M € | +9.3% | 99,7 M € | +3.0% | 96,7 M € | +0.3% | 96,4 M € | +5.5% | 91,3 M € | -18.2% | 111,7 M € | -4.2% | 116,6 M € | -1.1% | 117,9 M € | +7.3% | 109,9 M € | +14.7% | 95,9 M € | -6.2% | 102,2 M € | -9.8% | 113,2 M € | +11.4% | 101,7 M € | -15.4% | 120,2 M € | |
| Cash | 87,1 k € | -71.6% | 307,1 k € | -85.1% | 2,1 M € | -52.2% | 4,3 M € | +262.4% | 1,2 M € | -51.0% | 2,4 M € | +195.4% | 820,0 k € | +29.2% | 634,8 k € | -83.0% | 3,7 M € | +353.8% | 824,3 k € | -16.7% | 989,6 k € | -17.9% | 1,2 M € | -66.5% | 3,6 M € | +286.3% | 933,2 k € | +158.1% | 361,7 k € | -9.3% | 398,8 k € | -80.6% | 2,1 M € | +35.0% | 1,5 M € | -32.6% | 2,3 M € | |
| Debts | 226,2 M € | +30.5% | 173,3 M € | +57.7% | 109,9 M € | +117.7% | 50,5 M € | +133.0% | 21,7 M € | -11.7% | 24,5 M € | +25.3% | 19,6 M € | -9.4% | 21,6 M € | +1.6% | 21,2 M € | +0.7% | 21,1 M € | -56.5% | 48,5 M € | -27.7% | 67,1 M € | -8.6% | 73,3 M € | -44.4% | 132,0 M € | +12.4% | 117,5 M € | +3.5% | 113,5 M € | -8.3% | 123,8 M € | +17.3% | 105,6 M € | -3.7% | 109,6 M € | |
| Staff | 485 | 468,1 | 394 | 317,2 | 265,8 | 240,1 | 237,7 | 259,7 | 266,1 | 268,6 | 285,2 | 306,5 | 322,4 | 320 | 327,6 | 342 | 342,7 | 338,1 | 319,7 | |||||||||||||||||||
Public limited company · Braine-l'Alleud · incorporated on 14/02/2006 · 485,0 ETP
Public limited company profitable and well capitalised. Cash position declining (-71.6%).
Solid counterparty for a standard engagement.
PolyPeptide is a Public limited company incorporated in 2006. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Braine-l'Alleud. It employs on average 485,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette